IJGC Podcast

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Brooke Schlappe to discuss SLN vs Lymphadenectomy in high-risk endometrial cancer. Dr. Brooke Schlappe is a practicing gynecologic oncologist at Advocate Aurora Health in Milwaukee, WI where she serves as the Director of Gynecologic Oncology Clinical Research.

In this episode of the IJGC Podcast, Editorial Fellows Joanna Kacperczyk-Bartnik and Zoia Razumova discuss the contents of the August issue of IJGC.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Eduardo Bruera a to discuss updates on palliative care in gynecologic oncology. Dr. Eduardo Bruera is the F.T. McGraw Chair in the Treatment of Cancer, Department of Palliative, Rehabilitation and Integrative Medicine and the The University of Texas MD Anderson Cancer Center. Dr. Bruera’s main areas of interest are program development, comparative effectiveness research, and clinical studies on symptom control in palliative care. He has published more than 1200 publications, given more than 900 major invited lectures, and has received multiple NIH research grants and awards.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Anamaria Yeung to discuss patient reported outcomes from RTOG1203. Dr. Anamaria Yeung is an Associate Professor of Radiation Oncology at UF Health, with subspecialty expertise in gynecologic and thoracic malignancies. Her research interests include quality improvement and patient safety in radiation oncology, and reducing toxicity from radiation treatment and improving outcomes for women with gynecologic cancers.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Dimitrios Nasioudis a to discuss adjuvant treatment in UPSC limited to endometrium and his article, "Adjuvant treatment for patients with FIGO stage I uterine serous carcinoma confined to the endometrium," (https://ijgc.bmj.com/content/early/2020/07/14/ijgc-2020-001379) which is the Lead Article in the August 2020 issue of IJGC. Dr. Nasioudis is a resident at the Hospital of the University of Pennsylvania, Philadelphia. His current interests include population science and outcomes research with an emphasis on rare gynecologic tumors.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Oliver Zivanovic to discuss updates on role of HIPEC in ovarian cancer. Dr. Zivanovic is a Gynecologic Cancer Surgeon at Memorial Sloan Kettering Cancer Center, with the goal to advance the early detection and treatment of women with gynecologic cancers. His special interests include the treatment of patients with advanced stage ovarian cancer and electronic patient-reported symptom monitoring after cancer surgery.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Eleftheria Kalogera to discuss bowel preparation in gynecologic surgery. Dr. Kalogera is a gynecologic oncology fellow and assistant professor at Mayo Clinic. Her research is focused on the Enhanced Recovery After Surgery (ERAS) pathway, patient reported outcomes, and developmental therapeutics for women with gynecologic malignancies.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Warner Huh to discuss updates on HPV vaccination & guidelines. Warner K. Huh, MD is Professor, Vice Chair of Gynecology, Director of the Division of Gynecologic Oncology, and the Margaret Cameron Spain Endowed Chair in the Department of Obstetrics and Gynecology at the University of Alabama at Birmingham (UAB), Professor in the Department of Surgery, and Professor in the Department of Epidemiology in the UAB School of Public Health, and Senior Medical Officer and Senior Scientist in the UAB Comprehensive Cancer Center. His research interests include screening and prevention of HPV related diseases as well as novel immunotherapeutic approaches for pre-invasive disease of the cervix as well as cervical cancer. He serves as co-PI of the Johns Hopkins-UAB-University of Colorado Cervical Cancer Specialized Programs of Research Excellence (SPORE) program. He is on the steering committee for the ASCCP treatment guidelines and was co-chair of the ASCCP colposcopy standards effort.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Ainhoa Madariaga to discuss parp inhibitor treatments and adverse events. Dr. Madariaga's article, "Manage wisely: poly (ADP-ribose) polymerase inhibitor (PARPi) treatment and adverse events," (https://ijgc.bmj.com/content/early/2020/06/08/ijgc-2020-001288) is the Lead Article in the July 2020 issue of IJGC. Dr. Madariaga is a medical oncologist working as a clinical research fellow in the gynecology and drug development program at Princess Margaret Cancer Centre. Her clinical and academic areas of interest are gynecologic cancers and early phase clinical trial design; such as development of drug-repurposing studies, cancer treatment adverse event and patient reported outcomes assessment.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. A. Ilancheran to discuss updates in gestational trophoblastic disease. Dr Ilancheran works at the National University Hospital in Singapore and has been working as a gynecologic oncologist for the past 35 years, with special interest in Gestational Trophoblastic Disease and cervical cancer.